Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18:117–24. https://doi.org/10.2174/1570161117666190502103733.
Pan D, Guo J, Su Z, Wang J, Wu S, Guo J, Gu Y. Association of the controlling nutritional status score with all-cause mortality and cancer mortality risk in patients with type 2 diabetes: NHANES 1999–2018. Diabetol Metab Syndr. 2023;15:175. https://doi.org/10.1186/s13098-023-01138-2.
Collaborators GD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England). 2023;402:203–34. https://doi.org/10.1016/S0140-6736(23)01301-6.
Cloete L. Diabetes mellitus: an overview of the types, symptoms, complications and management. Nurs Stand. 2022;37:61–6. https://doi.org/10.7748/ns.2021.e11709.
Rao VRAL, Tan SH, Candasamy M, Bhattamisra SK. Diabetic nephropathy: an update on pathogenesis and drug development. Diabetes Metab Syndr. 2019;13:754–62. https://doi.org/10.1016/j.dsx.2018.11.054.
Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032–45. https://doi.org/10.2215/CJN.11491116.
Pelle MC, Provenzano M, Busutti M, Porcu CV, Zaffina I, Stanga L, Arturi F. Up-date on diabetic nephropathy. Life (Basel). 2022;12:1202. https://doi.org/10.3390/life12081202.
Cacciatore F, Testa G, Galizia G, Della-Morte D, Mazzella F, Langellotto A, Pirozzi G, Ferro G, Gargiulo G, Ferrara N, et al. Clinical frailty and long-term mortality in elderly subjects with diabetes. Acta Diabetol. 2013;50:251–60. https://doi.org/10.1007/s00592-012-0413-2.
Jiang S, Yu T, Zhang Z, Fang J, Wang Y, Yang Y, Liu L, Zou G, Gao H, Zhuo L, et al. Prognostic nomogram and score to predict renal survival of patients with biopsy-proven diabetic nephropathy. Diabetes Res Clin Pract. 2019;155:107809. https://doi.org/10.1016/j.diabres.2019.107809.
Mise K, Hoshino J, Ueno T, Hazue R, Hasegawa J, Sekine A, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, et al. Prognostic value of tubulointerstitial lesions, urinary N-Acetyl-β-d-glucosaminidase, and urinary β2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. Clin J Am Soc Nephrol. 2016;11:593–601. https://doi.org/10.2215/CJN.04980515.
Huang Y, Gou R, Diao Y, Yin Q, Fan W, Liang Y, Chen Y, Wu M, Zang L, Li L, et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B. 2014;15:58–66. https://doi.org/10.1631/jzus.B1300109.
Zhang H, Tian W, Sun Y. Development, validation, and visualization of a web-based nomogram to predict 5-year mortality risk in older adults with hypertension. BMC Geriatr. 2022;22:392. https://doi.org/10.1186/s12877-022-03087-3.
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, Wan X, Liu G, Wu D, Shi L, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31:1188–95. https://doi.org/10.1200/JCO.2012.41.5984.
Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy. Adv Nutr. 2016;7:121–34. https://doi.org/10.3945/an.115.009258.
Lu J, Chen K, Chen W, Liu C, Jiang X, Ma Z, Li D, Shen Y, Tian H. Association of serum homocysteine with cardiovascular and all-cause mortality in adults with diabetes: a prospective cohort study. Oxid Med Cell Longev. 2022;2022:2156483. https://doi.org/10.1155/2022/2156483.
Wallace AS, Chang AR, Shin J, Reider J, Echouffo-Tcheugui JB, Grams ME, Selvin E. Obesity and chronic kidney disease in US adults with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2022;107:1247–56. https://doi.org/10.1210/clinem/dgab927.
Qiu Z, Chen X, Geng T, Wan Z, Lu Q, Li L, Zhu K, Zhang X, Liu Y, Lin X, et al. Associations of serum carotenoids with risk of cardiovascular mortality among individuals with type 2 diabetes: results from NHANES. Diabetes Care. 2022;45:1453–61. https://doi.org/10.2337/dc21-2371.
Leino AD, Dorsch MP, Lester CA. Changes in statin use among U.S. adults with diabetes: a population-based analysis of NHANES 2011–2018. Diabetes Care. 2020;43:3110–2. https://doi.org/10.2337/dc20-1481.
Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74:796–804. https://doi.org/10.1016/j.eururo.2018.08.038.
Yu D, Shang J, Cai Y, Wang Z, Zhang X, Zhao B, Zhao Z, Simmons D. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study. BMJ Open Diabetes Res Care. 2019;7:e735. https://doi.org/10.1136/bmjdrc-2019-000735.
Mortada I. Hyperuricemia, type 2 diabetes mellitus, and hypertension: an emerging association. Curr Hypertens Rep. 2017;19:69. https://doi.org/10.1007/s11906-017-0770-x.
Jude EB, Anderson SG, Cruickshank JK, Srivatsa A, Tentolouris N, Chandrasekaran R, Gokal R, Boulton AJM. Natural history and prognostic factors of diabetic nephropathy in type 2 diabetes. QJM. 2002;95:371–7. https://doi.org/10.1093/qjmed/95.6.371.
Hishida M, Imaizumi T, Nishiyama T, Okazaki M, Kaihan AB, Kato S, Kubo Y, Ando M, Kaneda H, Maruyama S. Survival benefit of maintained or increased body mass index in patients undergoing extended-hours hemodialysis without dietary restrictions. J Ren Nutr. 2020;30:154–62. https://doi.org/10.1053/j.jrn.2019.06.002.
Ling W, Huang Y, Huang Y, Fan R, Sui Y, Zhao H. Global trend of diabetes mortality attributed to vascular complications, 2000–2016. Cardiovasc Diabetol. 2020;19:182. https://doi.org/10.1186/s12933-020-01159-5.
Wang L, Lv Y. Construction of a prediction model for the mortality of elderly patients with diabetic nephropathy. J Healthc Eng. 2022;2022:5724050. https://doi.org/10.1155/2022/5724050.
Sarkhosh SMH, Esteghamati A, Hemmatabadi M, Daraei M. Predicting diabetic nephropathy in type 2 diabetic patients using machine learning algorithms. J Diabetes Metab Disord. 2022;21:1433–41. https://doi.org/10.1007/s40200-022-01076-2.
Cha SA, Yun JS, Lim TS, Hwang S, Yim EJ, Song KH, Yoo KD, Park YM, Ahn YB, Ko SH. Severe hypoglycemia and cardiovascular or all-cause mortality in patients with type 2 diabetes. Diabetes Metab J. 2016;40:202–10. https://doi.org/10.4093/dmj.2016.40.3.202.
Wang S, Guo J, Liu X, Tian W, Zhang Y, Wang Y, Liu Y, E M, Fang S. Sexual dimorphism in mitochondrial dysfunction and diabetes mellitus: evidence from a population-based cohort study. Diabetol Metab Syndr. 2023;15:114. https://doi.org/10.1186/s13098-023-01090-1.
Byun S, Ma SH, Jun JK, Jung K, Park B. Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea. PLoS One. 2013;8:e62991. https://doi.org/10.1371/journal.pone.0062991.
Lee Y. Socioeconomic differences among community-dwelling diabetic adults screened for diabetic retinopathy and nephropathy: the 2015 Korean Community Health Survey. PLoS One. 2018;13:e191496. https://doi.org/10.1371/journal.pone.0191496.
Wolf G, Busch M, Müller N, Müller UA. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary centre. Nephrol Dial Transplant. 2011;26:4017–23. https://doi.org/10.1093/ndt/gfr185.
Jiang H, Zhang H, Zhang R. Construction and verification of predictive model for influencing factors of quality of life in patients with type 2 diabetic nephropathy: a hospital-based retrospective study. Arch Esp Urol. 2023;76:418–24. https://doi.org/10.56434/j.arch.esp.urol.20237606.51.
Tamakoshi A, Yatsuya H, Lin Y, Tamakoshi K, Kondo T, Suzuki S, Yagyu K, Kikuchi S, Group JS. BMI and all-cause mortality among Japanese older adults: findings from the Japan collaborative cohort study. Obesity (Silver Spring). 2010;18:362–9. https://doi.org/10.1038/oby.2009.190.
Wassertheil-Smoller S, Fann C, Allman RM, Black HR, Camel GH, Davis B, Masaki K, Pressel S, Prineas RJ, Stamler J, et al. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Arch Intern Med. 2000;160:494–500. https://doi.org/10.1001/archinte.160.4.494.
Yokomichi H, Mochizuki M, Hirata M, Nagai A, Kojima R, Horiuchi S, Ooka T, Akiyama Y, Shinohara R, Miyake K, et al. All-cause and cardiovascular disease mortality in underweight patients with diabetic nephropathy: BioBank Japan cohort. J Diabetes Investig. 2021;12:1425–9. https://doi.org/10.1111/jdi.13483.
Jung HN, Kim S, Jung CH, Cho YK. Association between body mass index and mortality in type 1 diabetes mellitus: a systematic review and meta-analysis. J Obes Metab Syndr. 2023;32:151–62. https://doi.org/10.7570/jomes22061.
Bell DSH, McGill JB, Jerkins T. Management of the ‘wicked’ combination of heart failure and chronic kidney disease in the patient with diabetes. Diabetes Obes Metab. 2023;25:2795–804. https://doi.org/10.1111/dom.15181.
Birkeland KI, Bodegard J, Eriksson JW, Norhammar A, Haller H, Linssen GCM, Banerjee A, Thuresson M, Okami S, Garal-Pantaler E, et al. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: a large multinational cohort study. Diabetes Obes Metab. 2020;22:1607–18. https://doi.org/10.1111/dom.14074.
Seki N, Matsumoto T, Fukazawa M. Relationship Between the Brain Natriuretic Peptide (BNP) level and prognosis of diabetic nephropathy with microalbuminuria: a 7-year follow-up study. Horm Metab Res. 2018;50:389–96. https://doi.org/10.1055/a-0603-3792.
Kim K, Lee J, Park J, Lee E, Moon J, Lee S, Lee J, Kim J, Kim H. Identification of novel biomarker for early detection of diabetic nephropathy. Biomedicines. 2021;9:457. https://doi.org/10.3390/biomedicines9050457.
Cai Y, Zhang H, Gao J, Cai Z, Cai J, Gao Q, Chen Z, Liao G, Zeng C, Chen N, et al. Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort. Diabetes Metab. 2023;49:101472. https://doi.org/10.1016/j.diabet.2023.101472.
Zhang J, Zhang R, Wang Y, Li H, Han Q, Wu Y, Wang T, Liu F. The level of serum albumin is associated with renal prognosis in patients with diabetic nephropathy. J Diabetes Res. 2019;2019:7825804. https://doi.org/10.1155/2019/7825804.
Komendarek-Kowalska M. The assessment of renal function in patients with newly diagnosed hypertension – the role of hyperuricemia as a risk factor for chronic kidney disease – preliminary study. Pol Merkur Lekarski. 2017;42:193–6.
- The Renal Warrior Project. Join Now
- Source: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03563-5